Objective: Given high rates of comorbidity, lack of awareness and global acceptance, and varying guidelines for its management, adult ADHD may be an especially difficult condition to diagnose and treat. The objective of this review was to explore and characterize similarities and differences among comorbidities associated with adult ADHD. Method: A review of the literature over the past 10 years was performed using Ovid. Results: A myriad of comorbid conditions such as impulse-control/personality, anxiety, mood, substance use, learning, and sleep disorders overlap with adult ADHD. Furthermore, a number of such conditions have symptoms that can mimic those of ADHD, including hyperactivity, impulsivity, inattention, and disruption of circadian rhythms, adding to the complexity of recognition and diagnosis of ADHD in adults. Extensive research shows that adults with ADHD appear to benefit from treatment with stimulant medications in similar ways as children, including significant improvements on driving performance. However, fear surrounding the abuse of stimulants is an important issue. Nevertheless, evidence suggests that children with ADHD who are treated with stimulant medication are less likely to develop a substance use disorder in adolescence and adulthood. Conclusion: There are a wide range of comorbidities with adult ADHD with many having overlapping symptoms. The benefits observed with ADHD treatment, however, emphasize the importance of recognition and treatment of adult ADHD.
AdlerL. A.GoodmanD. W.KollinsS. H.WeislerR. H.KrishnanS.ZhangY.BiedermanJ. (2008). Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 69, 1364-1373.
2.
AdlerL. A.GoodmanD.WeislerR.HamdaniM.RothT. (2009). Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder. Behavioral and Brain Function, 5, 34.
3.
AdlerL. A.ShawD.SittD.MayaE.MorrillM. (2009). Issues in the diagnosis and treatment of adult ADHD by primary care physicians. Primary Psychiatry, 16, 57-63.
4.
AdlerL. A.SpencerT. J.SteinM. A.NewcornJ. H. (2008). Best practices in adult ADHD: Epidemiology, impairments, and differential diagnosis. CNS Spectrums, 13, 1-19.
5.
AltfasJ. R. (2002). Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment. BMC Psychiatry, 2, 9.
6.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
7.
AmonsP. J.KooijJ. J.HaffmansP. M.HoffmanT. O.HoencampE. (2006). Seasonality of mood disorders in adults with lifetime attention-deficit/hyperactivity disorder (ADHD). Journal of Affective Disorders, 91, 251-255.
8.
AshersonP. (2004). Bridging the service gap: Invited commentary on attention-deficit hyperactivity disorder in adults. Advances in Psychiatric Treatment, 10, 257-259.
9.
AshersonP.ChenW.CraddockB.TaylorE. (2007). Adult attention-deficit hyperactivity disorder: Recognition and treatment in general adult psychiatry. British Journal of Psychiatry, 190, 4-5.
10.
BarkleyR. A.CoxD. (2007). A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. Journal of Safety Research, 38, 113-128.
11.
BekkerE. M.OvertoomC. C.KooijJ. J.BuitelaarJ. K.VerbatenM. N.KenemansJ. L. (2005). Disentangling deficits in adults with attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 62, 1129-1136.
12.
BiedermanJ. (2004). Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 65(Suppl. 3), 3-7.
13.
BiedermanJ.FaraoneS. V.SpencerT. J.WilensT.MickE.LapeyK. A. (1994). Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Research, 53, 13-29.
14.
BiedermanJ.FaraoneS. V.SpencerT. J.WilensT.NormanD.LapeyK. A.. . . DoyleA. (1993). Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry, 150, 1792-1798.
15.
BiedermanJ.MickE.SurmanC.DoyleR.HammernessP.HarpoldT.. . . SpencerT. (2006). A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biological Psychiatry, 59, 829-835.
16.
BiedermanJ.MonuteauxM. C.SpencerT.WilensT. E.MacPhersonH. A.FaraoneS. V. (2008). Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: A naturalistic controlled 10-year follow-up study. American Journal of Psychiatry, 165, 597-603.
17.
BiedermanJ.WilensT.MickE.MilbergerS.SpencerT. J.FaraoneS. V. (1995). Psychoactive substance use disorder in adults with attention deficit hyperactivity disorder (ADHD): Effects of ADHD and psychiatric comorbidity. American Journal of Psychiatry, 152, 1652-1658.
18.
BouffardR.HechtmanL.MindeK.Laboni-KassabF. (2003). The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder. Canadian Journal of Psychiatry, 48, 546-554.
19.
BuksteinO. (2008). Substance abuse in patients with attention-deficit/hyperactivity disorder. MedGenMed: Medscape General Medicine, 10, 24.
20.
CarpenterL. L.MilosavljevicN.SchecterJ. M.TyrkaA. R.PriceL. H. (2005). Augmentation with open-label atomoxetine for partial or nonresponse to antidepressants. Journal of Clinical Psychiatry, 66, 1234-1238.
21.
CarpentierP. J.de JongC. A.DijkstraB. A.VerbruggeC. A.KrabbeP. F. (2005). A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Addiction, 100, 1868-1874.
22.
CastellanosF. X.KellyC.MilhamM. P. (2009). The restless brain: Attention-deficit hyperactivity disorder, resting-state functional connectivity, and intrasubject variability. Canadian Journal of Psychiatry, 54, 665-672.
23.
CastellanosF. X.LeeP. P.SharpW.JeffriesN. O.GreensteinD. K.ClasenL. S.. . . RapoportJ. L. (2002). Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Medical Association, 288, 1740-1748.
24.
CastellsX.Ramos-QuirogaJ. A.BoschR.NogueiraM.CasasM. (2011). Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews, Issue 6. Art. No. CD007813. doi:10.1002/14651858.CD007813.pub210.1002/14651858.CD007813.pub2
25.
ChambersR. A.TaylorJ. R.PotenzaM. N. (2003). Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability. American Journal of Psychiatry, 160, 1041-1052.
26.
ChervinR. D.ArchboldK. H.DillonJ. E.PituchK. J.PanahiP.DahlR. E.GuilleminaultC. (2002). Associations between symptoms of inattention, hyperactivity, restless legs, and periodic leg movements. Sleep, 25, 213-218.
27.
ChervinR. D.DillonJ. E.BassettiC.GanoczyD. A.PituchK. J. (1997). Symptoms of sleep disorders, inattention, and hyperactivity in children. Sleep, 20, 1185-1192.
28.
CoghillD. (2004). Understudied and underrecognised: Invited commentary on attention-deficit hyperactivity disorder in adults. Advances in Psychiatric Treatment, 10, 338-340.
29.
ConradP.PotterD. (2000). From hyperactive children to ADHD adults: Observations on the expansion of medical categories. Social Problems, 47, 559-582.
30.
CornforthC.Sonuga-BarkeE.CoghillD. (2010). Stimulant drug effects on attention deficit/hyperactivity disorder: A review of the effects of age and sex of patients. Current Pharmaceutical Design, 16, 2424-2433.
31.
CorteseS.KonofalE.YatemanN.MourenM. C.LecendreuxM. (2006). Sleep and alertness in children with attention- deficit/hyperactivity disorder: A systematic review of the literature. Sleep, 29, 504-511.
32.
CoxD. J.HumphreyJ. W.MerkelR. L.PenberthyJ. K.KovatchevB. (2004). Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder. Journal of American Board Family Practice, 17, 235-239.
33.
CoxD. J.MerkelR. L.KovatchevB.SewardR. (2000). Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: A preliminary double-blind placebo-controlled trial. Journal of Nervous and Mental Disease, 188, 230-234.
34.
CoxD. J.MerkelR. L.MooreM.ThorndikeF.MullerC.KovatchevB. (2006). Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder. Pediatrics, 118, 704-710.
35.
CrabtreeV. M.IvanekoA.O’BrienL. M.GozalD. (2003). Periodic limb movement disorder of sleep in children. Journal of Sleep Research, 12, 73-81.
36.
DalbyJ. T. (1985). Will population decreases in caffeine consumption unveil attention deficit disorder in adults. Medical Hypotheses, 18, 163-167.
37.
EdvinssonD.BingeforsK.LindströmE.LewanderT. (2010). ADHD-related symptoms among adults in out-patient psychiatry and female prison inmates as compared with the general population. Upsala Journal of Medical Sciences, 115, 30-40.
38.
FaraoneS. V.BiedermanJ.WilensT. E.AdamsonJ. (2007). A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults. Psychological Medicine, 37, 1743-1752.
39.
FaraoneS. V.GlattS. J. (2010). A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. Journal of Clinical Psychiatry, 71, 754-763.
40.
FaraoneS. V.MickE. (2010). Molecular genetics of attention deficit hyperactivity disorder. Psychiatric Clinics of North America, 33, 159-180.
41.
FaraoneS. V.SpencerT.AleardiM.PaganoC.BiedermanJ. (2004). Meta-analyses of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology, 24, 24-29.
42.
FaraoneS. V.WilensT. W.PettyC.AntshelS.SpencerT.BiedermanJ. (2007). Substance use among ADHD adults: Implications of late onset and subthreshold diagnoses. American Journal on Addictions, 16, 24-34.
43.
FayyadJ.De GraafR.KesslerR.AlonsoJ.AngermeyerM.DemyttenaereK.. . . ZaslavskyA. M. (2007). Cross national prevalence and correlates of adult attention-deficit hyperactivity disorder. British Journal of Psychiatry, 190, 402-409.
44.
FeifelD.MacDonaldK. (2008). Attention-deficit/hyperactivity disorder in adults: Recognition and diagnosis of this often-overlooked condition. Postgraduate Medicine, 120, 39-47.
45.
FerrerM.AndiónO.MatalíJ.ValeroS.NavarroJ. A.Ramos-QuirogaJ. A.. . . CasasM. (2010). Comorbid attention-deficit/hyperactivity disorder in borderline patients defines an impulsive subtype of borderline personality disorder. Journal of Personality Disorders, 24, 812-822.
46.
FonesC. S.PollackM. H.SussweinL.OttoM. (2000). History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder. Journal of Affective Disorders, 58, 99-106.
47.
FossatiA.NovellaL.DonatiD.DoniniM.MaffeiC. (2002). History of childhood attention deficit/hyperactivity disorder symptoms and borderline personality disorder: A controlled study. Comprehensive Psychiatry, 43, 369-377.
48.
FuemmelerB. F.OstbyeT.YangC.McClernonF. J.KollinsS. H. (2011). Association between attention-deficit/hyperactivity disorder symptoms and obesity and hypertension in early adulthood: A population-based study. International Journal of Obesity, 35, 852-862.
49.
GinsbergY.HirvikoskiT.LindeforsN. (2010). Attention deficit hyperactivity disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder. BMC Psychiatry, 10, 112.
50.
GoksøyrP. K.NøttestadJ. A. (2008). The burden of untreated ADHD among adults: The role of stimulant medication. Addictive Behaviors, 33, 342-346.
HalmoyA.FasmerO. B.GillbergC.HaavikJ. (2009). Occupational outcome in adult ADHD: Impact of symptom profile, comorbid psychiatric problems, and treatment: A cross-sectional study of 414 clinically diagnosed adult ADHD patients. Journal of Attention Disorders, 13, 175-187.
53.
HesslingerB.Tebartz van ElstL.NybergE.DykierekP.RichterH.BernerM.EbertD. (2002). Psychotherapy of attention deficit hyperactivity disorder in adults: A pilot study using a structured skills training program. European Archives of Psychiatry & Clinical Neurosciences, 252, 177-184.
54.
HussM.LehmkuhlU. (2002). Methylphenidate and substance abuse: A review of pharmacology, animal and clinical studies. Journal of Attention Disorders, 6(Suppl. 1), S65-S71.
55.
HussM.PoustkaF.LehmkuhlG.LehmkuhlU. (2008). No increase in long-term risk for nicotine use disorders after treatment with methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD): Evidence from a non-randomised retrospective study. Journal of Neural Transmission, 115, 335-339.
KayG. C.MichaelsA.PakullB. (2009). Simulated driving changes in young adults with ADHD receiving mixed amphetamine salts extended release and atomoxetine. Journal of Attention Disorders, 12, 316-329.
58.
KesslerR. C.AkiskalH. S.AmesM.BirnbaumH.GreenbergP.HirschfeldM.. . . WangP. S. (2006). Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. American Journal of Psychiatry, 163, 1561-1568.
59.
KhantzianE. J. (1975). Self-selection and progression in drug dependence. Psychiatry Digest, 36, 19-22.
60.
KnivsbergA. M.AndreassenA. B. (2008). Behaviour, attention and cognition in severe dyslexia. Nordic Journal of Psychiatry, 62, 59-65.
61.
KoestersM.BeckerT.KilianR.FegertJ. M.WeinmannS. (2009). Limits of meta-analysis: Methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. Journal of Psychopharmacology, 23, 733-744.
62.
KolarD.KellerA.GolfinopoulosM.CumynL.SyerC.HechtmanL. (2008). Treatment of adults with attention-deficit/hyperactivity disorder. Neuropsychiatric Disease and Treatment, 4, 389-403.
63.
KollinsS. H.McClernonF. J.FuemmelerB. F. (2005). Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Archives of General Psychiatry, 62, 1142-1147.
64.
KooijJ. J. (2010). Adult ADHD: Diagnostic assessment and treatment. Amsterdam, Netherlands: Pearson Assessment and Information B. V.
65.
KooijJ. J.BejerotS.BlackwellA.CaciH.Casas-BruguéM.CarpentierP. J.. . . AshersonP. (2010). European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry, 10, 67.
66.
KooijJ. J.BurgerH.BoonstraA. M.Van der LindenP. D.KalmaL. E.BuitelaarJ. K. (2004). Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder: A randomized placebo-controlled double-blind cross-over trial. Psychological Medicine, 34, 973-982.
67.
KooijJ. J.MiddelkoopH. A.Van GilsK.BuitelaarJ. K. (2001). The effect of stimulants on nocturnal motor activity and sleep quality in adults with ADHD: An open-label case-control study. Journal of Clinical Psychiatry, 62, 952-956.
68.
KrauseJ.KrauseK. H.DreselS. H.La FougereC.AckenheilM. (2006). ADHD in adolescence and adulthood, with a special focus on the dopamine transporter and nicotine. Dialogues in Clinical Neuroscience, 8, 29-36.
69.
KupermanS.PerryP. J.GaffneyG. R.LundB. C.Bever-StilleK. A.ArndtS.. . . PaulsenJ. S. (2001). Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults. Annals of Clinical Psychiatry, 13, 129-134.
70.
LevinE. D.ConnersC. K.SilvaD.CanuW.MarchJ. (2001). Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. Experimental and Clinical Psychopharmacology, 9, 83-90.
71.
LevinF. R.EvansS. M.BrooksD. J.GarawiF. (2007). Treatment of cocaine dependent treatment seekers with adult ADHD: Double-blind comparison of methylphenidate and placebo. Drug and Alcohol Dependency, 87, 20-29.
72.
LevinF. R.EvansS. M.BrooksD. J.KalbagA. S.GarawiF.NunesE. V. (2006). Treatment of methadone-maintained patients with adult ADHD: Double-blind comparison of methylphenidate, bupropion and placebo. Drug and Alcohol Dependency, 81, 137-148.
73.
LevitanR. D.JainU. R.KatzmanM. A. (1999). Seasonal affective symptoms in adults with residual attention-deficit hyperactivity disorder. Comprehensive Psychiatry, 40, 261-267.
74.
LordS.DownsG.FurtawP.ChaudhuriA.SilversteinA.GammaitoniA.BudmanS. (2009). Nonmedical use of prescription opioids and stimulants among student pharmacists. Journal of the American Pharmacists Association, 49, 519-528.
75.
LouH. C.HenriksenL.BruhnP.BørnerH.NielsenJ. B. (1989). Striatal dysfunction in attention deficit and hyperkinetic disorder. Archives of Neurology, 46, 48-52.
76.
MannuzzaS.KleinR. G.BesslerA.MalloyP.LaPadulaM. (1993). Adult outcome of hyperactive boys: Educational achievement, occupational rank, and psychiatric status. Archives of General Psychiatry, 50, 565-576.
77.
MattesJ. A.BoswellL.OliverH. (1984). Methylphenidate effects on symptoms of attention deficit disorder in adults. Archives of General Psychiatry, 41, 1059-1063.
78.
McCarthyS.AshersonP.CoghillD.HollisC.MurrayM.PottsL.. . . WongI. C. (2009). Attention-deficit hyperactivity disorder: Treatment discontinuation in adolescent and young adults. British Journal of Psychiatry, 194, 273-277.
MeijerW. M.FaberA.Van den BanE.TobiH. (2009). Current issues around the pharmacotherapy of ADHD in children and adults. Pharmacy World & Science, 31, 509-516.
81.
MichelsonD.AdlerL.SpencerT.ReimherrF. W.WestS. A.AllenA. J.. . . MiltonD. (2003). Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies. Biological Psychiatry, 53, 112-120.
82.
MillerC. J.FloryJ. D.MillerS. R.HartyS. C.NewcornJ. H.HalperinJ. M. (2008). Childhood attention-deficit/hyperactivity disorder and the emergence of personality disorders in adolescence: A prospective follow-up study. Journal of Clinical Psychiatry, 69, 1477-1484.
83.
MossS. B.NairR.VallarinoA.WangS. (2007). Attention deficit/hyperactivity disorder in adults. Primary Care: Clinics in Office Practice, 34, 445-473.
84.
National Institute for Health and Clinical Excellence. (2009). The NICE guideline on attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults. Leicester, England, & London, England: The British Psychological Society & The Royal College of Psychiatrists. Retrieved from http://www.nice.org.uk/nicemedia/pdf/ADHDFullGuideline.pdf
85.
NewcornJ. H.WeissM.SteinM. A. (2007). The complexity of ADHD: Diagnosis and treatment of the adult patient with comorbidities. CNS Spectrums, 12(Suppl. 8), 1-16.
86.
OwensJ. A. (2005). The ADHD and sleep conundrum: A review. Journal of Developmental and Behavioral Pediatrics, 26, 312-322.
87.
PatersonR.DouglasC.HallmayerJ.HaganM.Krupenia. (1999). A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. Australian and New Zealand Journal of Psychiatry, 33, 494-502.
88.
PhilipsenA.FeigeB.HesslingerB.EbertD.CarlC.HornyakM.. . . RiemannD. (2005). Sleep in adults with attention deficit/hyperactivity disorder: A controlled polysomnographic study including spectral analysis of the sleep EEG. Sleep, 28, 877-884.
89.
PhilipsenA.HeblingerB.Van ElstL. T. (2008). Attention deficit hyperactivity disorder in adulthood. Deutsches Ärzteblatt International, 150, 311-317.
90.
PicchiettiD. L.UnderwoodD. J.FarrisW. A.WaltersA. S.ShahM. M.DahlR. E.. . . HeningW. A. (1999). Further studies on periodic limb movement disorder and restless legs syndrome, in children with attention-deficit hyperactivity disorder. Movement Disorders, 14, 1000-1007.
91.
PinkhardtE. H.KassubekJ.BrummerD.KoelchM.LudolphA. C.FegertJ. M.LudolphA. G. (2009). Intensified testing for attention-deficit hyperactivity disorder (ADHD) in girls should reduce depression and smoking in adult females and the prevalence of ADHD in the long term. Medical Hypotheses, 72, 409-412.
92.
PlichtaM. M.VasicN.WolfR. C.LeschK. P.BrummerD.JacobC.. . . GronG. (2009). Neural hyporesponsiveness and hyperresponsiveness during immediate and delayed reward processing in adult attention-deficit/hyperactivity disorder. Biological Psychiatry, 65, 7-14.
93.
RabinerD. L.AnastopoulosA. D.CostelloE. J.HoyleR. H.McCabeS. E.SwartzwelderH. S. (2009). The misuse and diversion of prescribed ADHD medications by college students. Journal of Attention Disorders, 13, 144-153.
94.
RamsayJ. R. (2007). Current status of cognitive-behavioral therapy as a psychosocial treatment for adult attention-deficit/hyperactivity disorder. Current Psychiatry Reports, 9, 427-433.
95.
ReimherrF. W.MarchantB. K.StrongR. E.HedgesD. W.AdlerL.SpencerT. J.. . . SoniP. (2005). Emotional dysregulation in adult ADHD and response to atomoxetine. Biological Psychiatry, 58, 125-131.
96.
ReimherrF. W.WilliamsE. D.StrongR. E.MestasR.SoniP.MarchantB. K. (2007). A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. Journal of Clinical Psychiatry, 68, 93-101.
97.
RobisonR. J.ReimherrF. W.MarchantB. K.FaraoneS. V.AdlerL. A.WestS. A. (2008). Gender differences in 2 clinical trials of adults with attention-deficit/hyperactivity disorder: A retrospective data analysis. Journal of Clinical Psychiatry, 69, 213-221.
98.
RostainA. L.RamsayJ. R. (2006). A combined treatment approach for adults with ADHD: Results of an open study of 43 patients. Journal of Attention Disorders, 10, 150-159.
99.
RostainA. L.RamsayJ. R. (2007). Psychosocial treatments for attention-deficit/hyperactivity disorder in adults: Current evidence and future directions. Professional Psychology, 38, 338-346.
100.
RucklidgeJ. J. (2008). Gender differences in ADHD: Implications for psychosocial treatment. Expert Reviews in Neurotherapeutics, 8, 643-655.
101.
RucklidgeJ. J. (2010). Gender differences in attention-deficit/hyperactivity disorder. Psychiatric Clinics of North America, 33, 357-373.
102.
RybakY. E.McNeelyH. E.MackenzieB. E.JainU. R.LevitanR. D. (2007). Seasonality and circadian preference in adult attention-deficit/hyperactivity disorder: Clinical and neuropsychological correlates. Comprehensive Psychiatry, 48, 562-571.
103.
SafrenS. A. (2006). Cognitive-behavioral approaches to ADHD treatment in adulthood. Journal of Clinical Psychiatry, 67(Suppl. 8), 46-50.
104.
SafrenS. A.OttoM. W.SprichS.WinettC. L.WilensT. E.BiedermanJ. (2005). Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behaviour Research and Therapy, 43, 831-842.
105.
SchachterH. M.PhamB.KingJ.LangfordS.MoherD. (2001). How efficacious and safe is a short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal, 27, 1475-1488.
106.
SchmitdtM. F.FilipponeP.EdelmanE. M. (2003). Social representations of attention deficit/hyperactivity disorder, 1988-1997. Culture and Psychology, 9, 383-406.
107.
SchubinerH.SaulesK. K.ArfkenC. L.JohansonC. E.SchusterC. R.LockhartN.. . . PihlgrenE. (2002). Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Expert Clinical Psychopharmacology, 10, 286-294.
108.
SemizU. B.BasogluC.OnerO.MunirK. M.AtesA.AlgulA.. . . CetinM. (2008). Effects of diagnostic comorbidity and dimensional symptoms of attention-deficit-hyperactivity disorder in men with antisocial personality disorder. Australian and New Zealand Journal of Psychiatry, 42, 405-413.
109.
SnyderS. M.HallJ. R. (2006). A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder. Journal of Clinical Neurophysiology, 23, 440-455.
110.
SobanskiE.SchredlM.KettlerN.AlmB. (2008). Sleep in adults with attention deficit hyperactivity disorder (ADHD) before and during treatment with methylphenidate: A controlled polysomnographic study. Sleep, 31, 375-381.
111.
SpencerR. M.IvryR. B.ZelaznikH. N. (2005). Role of the cerebellum in movements: Control of timing or movement transitions?Experimental Brain Research, 161, 383-396.
112.
SpencerT.BiedermanJ.WilensT. (1998). Adults with attention-deficit/hyperactivity disorder: A controversial diagnosis. . Journal of Clinical Psychiatry, 59(Suppl. 7), 59-68.
113.
SpencerT.BiedermanJ.WilensT. (2004). Nonstimulant treatment of adult attention-deficit/hyperactivity disorder. Psychiatric Clinics of North America, 27, 373-383.
114.
SpencerT.BiedermanJ.WilensT.DoyleR.SurmanC.PrinceJ.. . . FaraoneS. (2005). A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biological Psychiatry, 57, 456-463.
115.
SpencerT.BiedermanJ.WilensT.FaraoneS.PrinceJ.GerardK.. . . BearmanS. K. (2001). Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 58, 775-782.
116.
SpencerT. J.AdlerL. A.McGoughJ. J.MunizR.JiangH.PestreichL. (2007). Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biological Psychiatry, 15, 1380-1387.
117.
SpencerT. J.BiedermanJ.MadrasB. K.DoughertyD. D.BonabA. A.LivniE.. . . FischmanA. J. (2007). Further evidence of dopamine transporter dysregulation in ADHD: A controlled PET imaging study using altropane. Biological Psychiatry, 62, 1059-1061.
118.
SpencerT. J.BiedermanJ.WilensT.HardingM.O’DonnellD.GriffinS. (1996). Pharmacotherapy of attention deficit hyperactivity disorder across life cycle. A literature review. Journal of the American Academy of Child & Adolescent Psychiatry, 35, 409-432.
119.
SpencerT.WilensT.BiedermanJ.FaraoneS. V.AblonJ. S.LapeyK. (1995). A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Archives of General Psychiatry, 52, 434-443.
120.
StevensonC. S.StevensonR. J.WhitmontS. (2003). A self-directed psychosocial intervention with minimal therapist contact for adults with attention deficit hyperactivity disorder. Clinical Psychology and Psychotherapy, 10, 93-101.
121.
StevensonC. S.WhitmontS.BornholtL.LiveseyD.StevensonR. J. (2002). A cognitive remediation programme for adults with attention deficit hyperactivity disorder. Australian and New Zealand Journal of Psychiatry, 36, 610-616.
122.
TaylorF. B.RussoJ. (2000). Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. Journal of Child and Adolescent Psychopharmacology, 10, 311-320.
123.
TaylorF. B.RussoJ. (2001). Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology, 21, 223-228.
124.
TenenbaumS.PaullJ. C.SparrowE. P.DoddD. K.GreenL. (2002). An experimental comparison of pycnogenol and methylphenidate in adults with attention-deficit/hyperactivity disorder (ADHD). Journal of Attention Disorders, 6, 49-60.
125.
TorgersenT.GjervanB.RasmussenK. (2008). Treatment of adult ADHD: Is current knowledge useful to clinicians?Journal of Neuropsychiatric Disease and Treatment, 4, 177-186.
126.
TrottG. E. (2006). Attention-deficit/hyperactivity disorder (ADHD) in the course of life. European Archives of Psychiatry and Clinical Neurosciences, 256, 1-22.
127.
Van AmeringenM.ManciniC.SimpsonW.PattersonB. (2010). Adult attention deficit hyperactivity disorder in an anxiety disorders population. CNS Neuroscience and Therapeutics, 17, 221-226.
128.
Van der HeijdenK. B.SmitsM. G.Van SomerenE. J.GunningW. B. (2005). Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: A circadian rhythm sleep disorder. Chronobiology International, 22, 559-570.
129.
Van VeenM. M.KooijJ. J.BoonstraA. M.GordijnM. C.Van SomerenE. J. (2010). Delayed circadian rhythm in adults with attention-deficit/hyperactivity disorder and chronic sleep-onset insomnia. Biological Psychiatry, 67, 1091-1096.
130.
WaiteR.IveyN. (2009). Unveiling the mystery about adult ADHD: One woman’s journey. Issues in Mental Health Nursing, 30, 547-553.
131.
WassersteinJ. (2005). Diagnostic issues for adolescents and adults with ADHD. Journal of Clinical Psychology, 61, 535-547.
132.
WeislerR. H.BiedermanJ.SpencerT. J.WilensT. E.FaraoneS. V.ChrismanA. K.. . . TullochS. J. (2006). Mixed amphetamine salts extended-release in the treatment of adult ADHD: A randomized, controlled trial. CNS Spectrums, 11, 625-639.
133.
WeissM.HechtmanL. (2006). A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults. Journal of Clinical Psychiatry, 67, 611-619.
134.
WeissM. D.WeissJ. R. (2004). A guide to the treatment of adults with ADHD. Journal of Clinical Psychiatry, 65 (Suppl. 3), 27-37.
135.
WenderP. H.ReimherrF. W.WoodD.WardM. (1985). A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. American Journal of Psychiatry, 142, 547-552.
136.
WigalT.BramsM.GasiorM.GaoJ.SquiresL.GiblinJ. (2010). Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: Novel findings using a simulated adult workplace environment design. Behavioral and Brain Functions, 6, 34.
137.
WilensT. E. (2004). Impact of ADHD and its treatment on substance abuse in adults. Journal of Clinical Psychiatry, 65, 38-45.
138.
WilensT. E.BiedermanJ.WozniakJ.GunawardeneS.WongJ.MonuteauxM. (2003). Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults. Biological Psychiatry, 54, 1-8.
139.
WilensT. E.FaraoneS. V.BiedermanJ.GunawardeneS. (2003). Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics, 111, 179-185.
140.
WilensT. E.GignacM.SwezeyA.MonuteauxM. C.BiedermanJ. (2006). Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. Journal of the American Academy of Child & Adolescent Psychiatry, 45, 408-414.
141.
WilensT. E.SpencerT.BiedermanJ. (2002). A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder. Journal of Attention Disorders, 5, 189-202.
142.
WolfR. C.PlichtaM. M.SambataroF.FallgatterA. J.JacobC.LeschK. P.. . . VasicN. (2009). Regional brain activation changes and abnormal functional connectivity of the ventrolateral prefrontal cortex during working memory processing in adults with attention-deficit/hyperactivity disorder. Human Brain Mapping, 30, 2252-2266.
143.
WolkR.SomersV. K. (2007). Sleep and the metabolic syndrome. Experimental Physiology, 92, 67-78.
144.
WoodD. R.ReimherrF. W.WenderP. H.GlenE.JohnsonM. D. (1976). Diagnosis and treatment of minimal brain dysfunction in adults: A preliminary report. Archives of Gen Psychiatry, 33, 1453-1460.
145.
YoungS.ChesneyS.SperlingerD.MischP.CollinsP. (2009). A qualitative study exploring the life-course experiences of young offenders with symptoms and signs of ADHD who were detained in a residential care setting. Criminal Behaviour and Mental Health, 19, 54-63.
146.
ZametkinA. J.NordahlT. E.GrossM.KingA. C.SempleW. E.RumseyJ.. . . CohenR. M. (1990). Cerebral glucose metabolism in adults with hyperactivity of childhood onset. New England Journal of Medicine, 323, 1361-1366.
